IP Library Patent Application 17260071
Patent Application
App. No. 17/260,071

METHOD FOR EDITING DNA IN CELL-FREE SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/260,071
Abstract

A method for editing DNA in a cell-free system, the method including: (1) a step of introducing a deletion, substitution or addition at a target site of a DNA in a cell-free system, and (2) a step of amplifying, in a cell-free system, the DNA into which a deletion, substitution or addition has been introduced in step (1), wherein the DNA is amplified under temperature conditions that incubate at a temperature within a range from 20° C. to 80° C.

Claims (26)

1 . A method for editing DNA in a cell-free system, the method comprising the following steps:

(1) a step of introducing a deletion, substitution or addition at a target site of a DNA in a cell-free system, and

(2) a step of amplifying, in a cell-free system, the DNA into which a deletion, substitution or addition has been introduced in step (1), wherein the DNA is amplified under temperature conditions that incubate at a temperature within a range from 20° C. to 80° C.

2 . The method for editing DNA in a cell-free system according to claim 1 , the method comprising the following steps:

(1) a step of introducing a deletion, substitution or addition at a target site of a DNA in a cell-free system, and

(2) a step of amplifying, in a cell-free system, the DNA into which a deletion, substitution or addition has been introduced in step (1), wherein the DNA is amplified under temperature conditions that either incubate at a constant temperature, or incubate under a repeating temperature cycle in which incubation is conducted at two temperatures of 65° C. or lower.

3 . The method for editing DNA in a cell-free system according to claim 1 , the method comprising the following steps:

(1) a step of introducing a deletion, substitution or addition at a target site of a DNA in a cell-free system, and

(2) a step of amplifying, in a cell-free system, the DNA into which a deletion, substitution or addition has been introduced in step (1), wherein the DNA is amplified under temperature conditions that either incubate at a fixed temperature within a range from 20° C. to 80° C., or incubate under a repeating temperature cycle in which incubation is conducted at two temperatures of 65° C. or lower.

4 . The method according to claim 1 , wherein step (2) is conducted in presence of an artificial DNA cleavage enzyme that specifically cleaves DNA into which a deletion, substitution or addition has not been introduced.

5 . The method according to claim 4 , wherein the artificial DNA cleavage enzyme is an artificial nuclease or an RNA-guided nuclease.

6 . The method according to claim 4 , wherein the artificial DNA cleavage enzyme is CRISPR-Cas9.

7 . The method according to claim 1 , wherein the DNA is a circular DNA.

8 . The method according to claim 7 , wherein step (2) comprises the following steps:

(2-1) a step of preparing a reaction mixture of: a reaction solution comprising (a) a first enzyme group that catalyzes replication of the circular DNA, (b) a second enzyme group that catalyzes an Okazaki fragment ligation reaction and synthesizes two sister circular DNAs that form a catenane, and (c) a third enzyme group that catalyzes a separation reaction of the two sister circular DNAs; and the circular DNA into which a deletion, substitution or addition has been introduced in step (1); and

(2-2) a step of incubating the reaction mixture prepared in step (2-1), either at a fixed temperature within a range from 20° C. to 80° C., or under a repeating temperature cycle in which incubation is conducted at two temperatures of 65° C. or lower.

9 . The method according to claim 8 , wherein the circular DNA contains a replication origin sequence that can bind to an enzyme having DnaA activity.

10 . The method according to claim 7 , wherein in step (2), the circular DNA is amplified by rolling circle amplification.

11 . The method according to claim 1 , wherein step (1) comprises the following steps:

(1-1) a step of cleaving the DNA at a target site to prepare at least one linear DNA by causing an artificial DNA cleavage enzyme to act upon the DNA;

(1-2) a step of preparing a reaction solution containing the linear DNA prepared in step (1-1), one or more types of DNA fragment, and a protein having RecA family recombinase activity; and

(1-3) a step of mutually joining the linear DNA and the one or more types of DNA fragment at regions in which base sequences are homologous or at regions in which base sequences are complementary, thereby forming a DNA in which the one or more types of DNA fragment have each been inserted at a target site of a template DNA.

12 . The method according to claim 1 , wherein step (1) comprises the following step:

a step of conducting a DNA replication reaction in presence of a single-stranded DNA used for introducing a deletion, substitution or addition, wherein the single-stranded DNA can hybridize with a target site of the DNA under the replication reaction conditions.

13 . The method according tom claim 1 , wherein in step (2), the DNA is amplified under temperature conditions that incubate under a temperature cycle that repeats incubation at 30° C. or higher and incubation at 27° C. or lower.

14 . The method according tom claim 1 , wherein a size of the DNA into which a deletion, substitution or addition has been introduced is 50 kb or larger.

Assignments (3)
CHANGE OF NAME Recorded May 4, 2023
From: ORICIRO GENOMICS K.K.
To: MODERNA ENZYMATICS CO., LTD.
Reel/Frame 063534/0546 →
CHANGE OF NAME Recorded May 4, 2023
From: ORICIRO GENOMICS, INC.
To: ORICIRO GENOMICS K.K.
Reel/Frame 064657/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2021
From: SUETSUGU, MASAYUKI; TAWARAGI, AYAKO; KANOH, KOKI
To: ORICIRO GENOMICS, INC.
Reel/Frame 054906/0630 →